Astonea Labs — 360° view

Astonea Labs, a company in the Pharmaceuticals industry, reported revenue of ₹81 crore and net profit of ₹3.00 crore for the March 2026 quarter.

Astonea Labs (BSE: ASTONEALAB) closed at ₹414.00 on 20 Nov 2026, up 191.3% over the past year. Its market capitalisation is ₹435 crore and it trades at 96.3 times earnings.

Share price
₹414.00 (20 Nov 2026)
Market cap
₹435 Cr (20 Nov 2026)
P/E
96.27 (20 Nov 2026)
Revenue
₹81 Cr (March 2026 quarter)
Net profit
₹3 Cr (March 2026 quarter)
ROCE
10.5% (FY26)
ROE
12.0% (FY26)
Book value
₹54.4 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹420.00 / ₹118.00 (20 Nov 2026)
1-year return
191.3% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: ASTONEALAB

Incorporated in 2017, Astonea Labs Ltd. is engaged in contract manufacturing of pharmaceutical and cosmetic products for companies

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.